Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 110.06M
March 31, 2026 85.31M
December 31, 2025 85.84M
September 30, 2025 11.53M
June 30, 2025 77.82M
March 31, 2025 77.58M
December 31, 2024 80.74M
September 30, 2024 82.55M
June 30, 2024 83.35M
March 31, 2024 84.19M
December 31, 2023 85.07M
September 30, 2023 86.10M
June 30, 2023 87.08M
March 31, 2023 87.75M
September 30, 2022 88.30M
June 30, 2022 19.07M
March 31, 2022 20.78M
December 31, 2021 20.37M
Date Value
September 30, 2021 21.27M
June 30, 2021 22.37M
March 31, 2021 20.01M
December 31, 2020 19.68M
September 30, 2020 17.13M
June 30, 2020 18.56M
March 31, 2020 19.19M
December 31, 2019 21.53M
September 30, 2019 20.61M
June 30, 2019 15.41M
March 31, 2019 0.0276M
December 31, 2018 0.0343M
September 30, 2018 0.0414M
June 30, 2018 0.0494M
March 31, 2018 0.0574M
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 166.19M
UroGen Pharma Ltd. 195.44M
Ironwood Pharmaceuticals, Inc. 393.58M
Viking Therapeutics, Inc. 3.925M
IDEAYA Biosciences, Inc. 28.12M